PTPN11, SOS1, KRAS, and RAF1 Gene Analysis, and Genotype-phenotype Correlation in Korean Patients with Noonan Syndrome

Overview

Journal J Hum Genet

Specialty Genetics

Date 2008 Nov 21

PMID 19020799

Citations 38

Authors

Jung Min Ko

Jae-Min Kim

Gu-Hwan Kim

Han-Wook Yoo

Affiliations

Soon will be listed here.

Abstract

After 2006, germline mutations in the KRAS, SOS1, and RAF1 genes were reported to cause Noonan syndrome (NS), in addition to the PTPN11 gene, and now we can find the etiology of disease in approximately 60-70% of NS cases. The aim of this study was to assess the correlation between phenotype and genotype by molecular analysis of the PTPN11, SOS1, KRAS, and RAF1 genes in 59 Korean patients with NS. We found disease-causing mutations in 30 (50.8%) patients, which were located in the PTPN11 (27.1%), SOS1 (16.9%), KRAS (1.7%), and RAF1 (5.1%) genes. Three novel mutations (T59A in PTPN11, K170E in SOS1, S259T in RAF1) were identified. The patients with PTPN11 mutations showed higher prevalences of patent ductus arteriosus and thrombocytopenia. The patients with SOS1 mutations had a lower prevalence of delayed psychomotor development. All patients with RAF1 mutations had hypertrophic cardiomyopathy. Typical facial features and auxological parameters were, on statistical analysis, not significantly different between the groups. The molecular defects of NS are genetically heterogeneous and involve several genes other than PTPN11 related to the RAS-MAPK pathway.

Citing Articles

Optimized phenotyping of complex morphological traits: enhancing discovery of common and rare genetic variants.

Yuan M, Goovaerts S, Lee M, Devine J, Richmond S, Walsh S Brief Bioinform. 2025; 26(2).

PMID: 40062617 PMC: 11891655. DOI: 10.1093/bib/bbaf090.

Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives.

Aghili Z, Khoshnevisan G, Mostoli R, Alibaglouei M, Zarkesh-Esfahani S Mol Biol Rep. 2025; 52(1):202.

PMID: 39904816 DOI: 10.1007/s11033-025-10304-w.

Noonan syndrome and Noonan-like syndrome with loose anagen hair: rare phenotypes may emerge during follow-up.

Liu Z, Lai J, Song F Transl Pediatr. 2024; 13(7):1161-1168.

PMID: 39144424 PMC: 11320002. DOI: 10.21037/tp-24-113.

Spectrum of Mutations in in Russian Cohort.

Orlova A, Guseva D, Demina N, Polyakov A, Ryzhkova O Genes (Basel). 2024; 15(3).

PMID: 38540404 PMC: 10970286. DOI: 10.3390/genes15030345.

Hashimoto's Thyroiditis in Noonan Syndrome: A Case Report.

Khan Q, Levin-Carrion Y, Khan R, Khan A, Saddiq S, Guddeti V Cureus. 2024; 16(1):e51592.

PMID: 38313927 PMC: 10836615. DOI: 10.7759/cureus.51592.

References

Sharland M, Burch M, McKenna W, Paton M . A clinical study of Noonan syndrome. Arch Dis Child. 1992; 67(2):178-83. PMC: 1793396. DOI: 10.1136/adc.67.2.178. View

Allanson J, Hall J, Hughes H, Preus M, Witt R . Noonan syndrome: the changing phenotype. Am J Med Genet. 1985; 21(3):507-14. DOI: 10.1002/ajmg.1320210313. View

Zenker M, Horn D, Wieczorek D, Allanson J, Pauli S, van der Burgt I . SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet. 2007; 44(10):651-6. PMC: 2597961. DOI: 10.1136/jmg.2007.051276. View

Limal J, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S . Noonan syndrome: relationships between genotype, growth, and growth factors. J Clin Endocrinol Metab. 2005; 91(1):300-6. DOI: 10.1210/jc.2005-0983. View

Tartaglia M, Kalidas K, Shaw A, Song X, Musat D, van der Burgt I . PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002; 70(6):1555-63. PMC: 379142. DOI: 10.1086/340847. View

Abdur Razzaque M, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R . Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007; 39(8):1013-7. DOI: 10.1038/ng2078. View

Zenker M, Lehmann K, Schulz A, Barth H, Hansmann D, Koenig R . Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet. 2006; 44(2):131-5. PMC: 2598066. DOI: 10.1136/jmg.2006.046300. View

Isgaard J . Cardiovascular disease and risk factors: the role of growth hormone. Horm Res. 2004; 62 Suppl 4:31-8. DOI: 10.1159/000080906. View

Raaijmakers R, Noordam C, Karagiannis G, Gregory J, Hertel N, Sipila I . Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database. J Pediatr Endocrinol Metab. 2008; 21(3):267-73. DOI: 10.1515/jpem.2008.21.3.267. View

10.

Schubbert S, Zenker M, Rowe S, Boll S, Klein C, Bollag G . Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006; 38(3):331-6. DOI: 10.1038/ng1748. View

11.

Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W . Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004; 144(3):368-74. DOI: 10.1016/j.jpeds.2003.11.032. View

12.

van der Burgt I . Noonan syndrome. Orphanet J Rare Dis. 2007; 2:4. PMC: 1781428. DOI: 10.1186/1750-1172-2-4. View

13.

Lee S, Ki C, Lee H . Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome. Clin Genet. 2007; 72(2):150-5. DOI: 10.1111/j.1399-0004.2007.00839.x. View

14.

Ng P, Henikoff S . SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812-4. PMC: 168916. DOI: 10.1093/nar/gkg509. View

15.

Musante L, Kehl H, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G . Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet. 2003; 11(2):201-6. DOI: 10.1038/sj.ejhg.5200935. View

16.

Muslin A . Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc Med. 2005; 15(6):225-9. DOI: 10.1016/j.tcm.2005.06.008. View

17.

Sarkozy A, Conti E, Seripa D, Digilio M, Grifone N, Tandoi C . Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet. 2003; 40(9):704-8. PMC: 1735592. DOI: 10.1136/jmg.40.9.704. View

18.

Pandit B, Sarkozy A, Pennacchio L, Carta C, Oishi K, Martinelli S . Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007; 39(8):1007-12. DOI: 10.1038/ng2073. View

19.

Tartaglia M, Niemeyer C, Fragale A, Song X, Buechner J, Jung A . Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34(2):148-50. DOI: 10.1038/ng1156. View

20.

Tartaglia M, Pennacchio L, Zhao C, Yadav K, Fodale V, Sarkozy A . Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2006; 39(1):75-9. DOI: 10.1038/ng1939. View